General Pharmacology Practice Questions

Q: Plasma drug monitoring is indicated for which type of drug?

Drugs with a narrow therapeutic index. **Explanation:** **Therapeutic Drug Monitoring (TDM)** is the clinical practice of measuring drug concentrations in plasma to maintain them within a specific "therapeutic window." **Why Option B is Correct:** Drugs with a **narrow therapeutic index (NTI)** have a very small margin between the dose required for a therapeutic effect and the dose that causes toxicity. For these drugs, standard dosing can lead to unpredictable plasma levels due to individual pharmacokinetic variations. Monitoring is essential to ensure efficacy while preventing life-threatening toxicity. Examples include Digoxin, Lithium, Phenytoin, and Aminoglycosides. **Why Other Options are Incorrect:** * **Options A & C:** Drugs with a **high or wide therapeutic index** (e.g., Penicillin, Paracetamol) are inherently safer. The dose required to produce toxicity is significantly higher than the effective dose. Therefore, routine plasma monitoring is unnecessary and not cost-effective, as clinical observation usually suffices. **NEET-PG High-Yield Pearls:** * **Indications for TDM:** Narrow therapeutic index, drugs with high first-pass metabolism, non-compliance suspected, or when toxicity is difficult to distinguish from the disease itself (e.g., Digoxin-induced arrhythmias). * **TDM is NOT useful for:** "Hit and run" drugs (e.g., Reserpine, MAO inhibitors), drugs with easily measurable physiological markers (e.g., BP for antihypertensives, INR for Warfarin, Blood sugar for Insulin), and irreversible inhibitors. * **Mnemonic for NTI Drugs:** **W**arfarin, **T**heophylline, **D**igoxin, **L**ithium, **P**henytoin (**W**hen **T**he **D**rugs **L**evels **P**eak).

Q: Which of the following is true regarding drugs administered intravenously?

They have 100% bioavailability.. ### Explanation **1. Why Option C is Correct:** Bioavailability is defined as the fraction of an administered dose of unchanged drug that reaches the systemic circulation. When a drug is administered **intravenously (IV)**, it is injected directly into the bloodstream, bypassing all barriers to absorption (like the gut wall) and avoiding initial metabolism by the liver. Therefore, the entire dose reaches the systemic circulation, resulting in **100% bioavailability ($F = 1.0$)**. This makes the IV route the gold standard for comparing the bioavailability of other routes. **2. Why Other Options are Incorrect:** * **Option A:** "Absorption" refers to the movement of a drug from its site of administration into the central compartment. Since IV drugs are placed directly into the blood, they **bypass the process of absorption** entirely. Absorption is a prerequisite for oral, subcutaneous, or intramuscular routes, but not for IV. * **Option B:** First-pass metabolism occurs when a drug is metabolized (usually in the liver or gut wall) before it reaches systemic circulation. IV drugs enter the systemic veins directly and reach the heart/lungs before being distributed to the liver via the hepatic artery. Thus, they **escape first-pass metabolism**. **3. NEET-PG High-Yield Pearls:** * **Bioavailability ($F$):** Calculated as $\frac{\text{AUC (oral)}}{\text{AUC (IV)}} \times 100$. * **Emergency Use:** The IV route is the route of choice in emergencies due to its **instantaneous onset of action**. * **Loading Dose:** Drugs with large volumes of distribution ($V_d$) often require an IV loading dose to achieve rapid therapeutic plasma concentrations. * **Caution:** IV administration carries the highest risk of toxicity and "speed shock" if injected too rapidly; it is also the most difficult route to reverse once the drug is given.

Q: Which of the following is NOT a type of oxidative drug metabolism?

Glucuronidation. ### Explanation Drug metabolism (biotransformation) is divided into two main phases: **Phase I (Non-synthetic)** and **Phase II (Synthetic)**. **Why Glucuronidation is the Correct Answer:** Glucuronidation is a **Phase II reaction**. It involves the conjugation of a drug with glucuronic acid (derived from glucose) via the enzyme **UDP-glucuronosyltransferase (UGT)**. Unlike Phase I reactions, which introduce or expose functional groups, Phase II reactions attach large, polar endogenous molecules to the drug to make it water-soluble for excretion. **Why the other options are incorrect:** Options A, B, and C are all subtypes of **Phase I Oxidative reactions**, primarily mediated by the **Cytochrome P450 (CYP450)** enzyme system: * **Deamination (A):** Removal of an amino group (e.g., metabolism of Amphetamine). * **N-oxidation (B):** Addition of oxygen to a nitrogen atom (e.g., metabolism of Trimethylamine). * **N-dealkylation (C):** Removal of an alkyl group attached to a nitrogen atom (e.g., Morphine to Normorphine). **High-Yield Clinical Pearls for NEET-PG:** * **Phase I Reactions:** Oxidation (most common), Reduction, and Hydrolysis. * **Phase II Reactions:** Glucuronidation (most common Phase II), Acetylation, Methylation, and Sulfate conjugation. * **Microsomal vs. Non-microsomal:** Glucuronidation is the **only** Phase II reaction carried out by microsomal enzymes (located in the smooth ER). All other Phase II reactions are non-microsomal (cytosolic). * **Gray Baby Syndrome:** Occurs in neonates due to a deficiency of the UGT enzyme, leading to the inability to conjugate Chloramphenicol.

Q: Which of the following receptors has an intrinsic ion channel?

GABA-benzodiazepine receptor. ### Explanation **1. Why the Correct Answer is Right:** The **GABA-A receptor** (part of the GABA-benzodiazepine receptor complex) is a classic example of a **Ligand-Gated Ion Channel (Ionotropic Receptor)**. It is a pentameric structure that, upon activation by GABA, opens an intrinsic **Chloride (Cl⁻) channel**. The resulting influx of chloride ions causes hyperpolarization of the post-synaptic neuron, leading to CNS inhibition. Benzodiazepines act as positive allosteric modulators, increasing the *frequency* of channel opening. **2. Why the Other Options are Incorrect:** * **Histamine H1 & H2 Receptors:** Both are **G-Protein Coupled Receptors (GPCRs)**. H1 is coupled to the **Gq** protein (activating the PLC-IP3/DAG pathway), while H2 is coupled to the **Gs** protein (increasing cAMP). * **Adrenergic Alpha Receptors:** All adrenergic receptors (Alpha and Beta) are **GPCRs**. Alpha-1 is Gq-linked, while Alpha-2 is Gi-linked (inhibitory). They do not contain intrinsic ion channels. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ionotropic Receptors (Fastest):** Include Nicotinic ACh (Na⁺/K⁺), GABA-A (Cl⁻), Glycine (Cl⁻), and 5-HT3 (Na⁺/K⁺). Note: 5-HT3 is the *only* serotonin receptor that is ionotropic. * **Metabotropic Receptors (GPCRs):** These are the most common targets for drugs. They act via second messengers (cAMP, IP3, DAG). * **GABA-B:** Unlike GABA-A, the GABA-B receptor is a **GPCR** (linked to Gi) that works by opening K⁺ channels or closing Ca²⁺ channels. * **Benzodiazepines vs. Barbiturates:** Benzodiazepines increase the **frequency** of Cl⁻ channel opening; Barbiturates increase the **duration** of opening.

Q: What type of antagonism does protamine exhibit towards heparin?

Chemical. ### Explanation **Correct Answer: B. Chemical Antagonism** **Why it is correct:** Chemical antagonism occurs when two substances react chemically in solution to form an inactive product, thereby neutralizing the effect of one another without involving a specific receptor site. * **Heparin** is a highly acidic, negatively charged molecule (due to sulfate groups). * **Protamine sulfate** is a highly basic, positively charged protein (rich in arginine). When administered, protamine binds ionically to heparin to form a stable, inactive **salt complex**. This direct chemical neutralization makes it the classic example of chemical antagonism. **Why the other options are incorrect:** * **A & D (Competitive and Noncompetitive):** These are types of **pharmacologic antagonism** where the antagonist competes for or binds to the same receptor as the agonist. Heparin does not act through a traditional receptor; it acts by activating Antithrombin III in the plasma. * **C (Toxic):** This is not a standard classification of antagonism. While protamine can have toxic effects (like hypotension or anaphylaxis) if given too rapidly, the term describes a side effect profile rather than the mechanism of interaction. **NEET-PG High-Yield Pearls:** * **Antidote Ratio:** 1 mg of Protamine neutralizes approximately 100 units of Heparin. * **Source:** Protamine is derived from the sperm of salmon or other fish. * **Clinical Caution:** Rapid injection of protamine can cause histamine release, leading to systemic hypotension and pulmonary hypertension. * **Other Examples of Chemical Antagonism:** * Chelating agents (e.g., Dimercaprol) binding to heavy metals. * Antacids neutralizing gastric HCl.

Q: Fenfluramine is used in which of the following conditions?

Obesity. **Fenfluramine** is a sympathomimetic amine that acts primarily as a **serotonin-releasing agent**. It increases the level of extracellular serotonin in the hypothalamus, which stimulates the satiety center and suppresses appetite (anorexiant effect). Historically, it was widely used for the management of **Obesity** (Option A) [1], often in combination with phentermine (the "Fen-Phen" regimen).Why other options are incorrect:* **Malignancy (Option B):** Fenfluramine has no cytotoxic or anti-neoplastic properties. In fact, weight loss is a common complication of malignancy (cachexia), where appetite stimulants (like Megestrol) would be indicated instead.* **Hypertension (Option C):** Fenfluramine is contraindicated in hypertension. As a sympathomimetic, it can increase blood pressure. Furthermore, its use is strongly associated with **Pulmonary Arterial Hypertension (PAH)** [2].**High-Yield NEET-PG Pearls:**1. **Withdrawal:** Fenfluramine was withdrawn from the global market in 1997 due to serious adverse effects, specifically **cardiac valvular fibrosis** and **Pulmonary Hypertension** [2].2. **Mechanism of Toxicity:** The valvular damage is mediated by the activation of **5-HT2B receptors** on cardiac valvular interstitial cells.3. **Recent Update:** In 2020, low-dose Fenfluramine was FDA-approved for a new indication: the treatment of seizures associated with **Dravet Syndrome** and **Lennox-Gastaut Syndrome** (pediatric epileptic encephalopathies).4. **Isomer:** **Dexfenfluramine** is the d-isomer of fenfluramine, which was also used for obesity before being withdrawn for similar cardiac risks [2].

Q: What is the mechanism of action of sildenafil?

Inhibition of phosphodiesterase-5. **Explanation:** **Mechanism of Action:** Sildenafil is a selective inhibitor of **Phosphodiesterase-5 (PDE-5)**. In the corpus cavernosum, sexual stimulation leads to the release of Nitric Oxide (NO), which activates the enzyme guanylyl cyclase [1, 5]. This increases levels of **cyclic Guanosine Monophosphate (cGMP)**, causing smooth muscle relaxation and increased blood flow (erection) [3, 5]. PDE-5 is the enzyme responsible for the degradation of cGMP. By inhibiting PDE-5, sildenafil prevents the breakdown of cGMP, thereby enhancing and prolonging the vasodilatory effect of NO [1, 3]. **Analysis of Incorrect Options:** * **Option A (Adenosine deaminase):** Inhibited by drugs like **Pentostatin**, used in hairy cell leukemia. * **Option C (Aminopeptidase):** Inhibited by **Bestatin** (Ubenimex), an immunomodulator. * **Option D (Guanylyl cyclase):** Sildenafil actually *potentiates* the downstream effects of this enzyme; it does not inhibit it. Drugs like nitrates stimulate guanylyl cyclase [3]. **NEET-PG High-Yield Pearls:** * **Clinical Uses:** Erectile dysfunction and **Pulmonary Arterial Hypertension (PAH)** [1, 3]. * **Contraindication:** Must never be co-administered with **Nitrates** (e.g., Nitroglycerin) as it can cause life-threatening hypotension due to synergistic increases in cGMP [3]. * **Side Effects:** Headache, flushing, and **Cyanopsia** (blue-tinted vision) due to weak cross-inhibition of PDE-6 in the retina. * **Tadalafil vs. Sildenafil:** Tadalafil has a much longer half-life (approx. 18 hours) compared to sildenafil (approx. 4 hours).

Q: Sildenafil acts by which mechanism?

Increasing cGMP. ### Explanation **Mechanism of Action (Why A is correct):** Sildenafil is a selective inhibitor of the enzyme **Phosphodiesterase-5 (PDE-5)**. In the corpus cavernosum of the penis and the pulmonary vasculature, Nitric Oxide (NO) stimulates the enzyme guanylyl cyclase, which converts GTP into **cyclic Guanosine Monophosphate (cGMP)**. cGMP causes smooth muscle relaxation and vasodilation. Normally, PDE-5 breaks down cGMP to terminate this signal. By inhibiting PDE-5, Sildenafil prevents the degradation of cGMP, leading to its **increased levels**, prolonged vasodilation, and improved erectile function. **Analysis of Incorrect Options:** * **B (Decreasing cGMP):** This would cause vasoconstriction and smooth muscle contraction, the opposite of Sildenafil’s intended effect. * **C & D (cAMP pathways):** While drugs like Milrinone (PDE-3 inhibitor) or Alprostadil (PGE1 analog) work via the **cyclic Adenosine Monophosphate (cAMP)** pathway, Sildenafil is highly selective for PDE-5, which specifically degrades cGMP, not cAMP. **NEET-PG High-Yield Pearls:** * **Clinical Uses:** Erectile dysfunction and Pulmonary Arterial Hypertension (PAH). * **Absolute Contraindication:** Never co-administer with **Nitrates** (e.g., Nitroglycerin). Both increase cGMP through different mechanisms, leading to synergistic vasodilation and potentially fatal hypotension. * **Side Effects:** Headache, flushing, and **Cyanopsia** (blue-tinted vision) due to weak inhibition of PDE-6 in the retina. * **Metabolism:** Primarily by **CYP3A4**; inhibitors like Erythromycin or Ketoconazole can increase its toxicity.

Question 1

Plasma drug monitoring is indicated for which type of drug?

Accepted Answer

Drugs with a narrow therapeutic index

Answer

Drugs with a high safety margin

Answer

Drugs with a wide therapeutic index

Answer

None of the above

Question 2

Which of the following is true regarding drugs administered intravenously?

Accepted Answer

They have 100% bioavailability.

Answer

They are rapidly absorbed.

Answer

They are subject to first-pass metabolism.

Answer

All of the above.

Question 3

At 12 hours after intravenous administration of a bolus dose, the plasma level of a drug is 3 mg/L. If the volume of distribution (Vd) is 10 L and the elimination half-life is 6 hours, what was the dose administered?

Accepted Answer

120 mg

Answer

180 mg

Answer

240 mg

Answer

480 mg

Question 4

Which of the following is NOT a type of oxidative drug metabolism?

Accepted Answer

Glucuronidation

Answer

Deamination

Answer

N-oxidation

Answer

N-dealkylation

Question 5

Which of the following receptors has an intrinsic ion channel?

Accepted Answer

GABA-benzodiazepine receptor

Answer

Histamine H1 receptor

Answer

Histamine H2 receptor

Answer

Adrenergic alpha receptor

Question 6

What type of antagonism does protamine exhibit towards heparin?

Accepted Answer

Chemical

Answer

Competitive

Answer

Toxic

Answer

Noncompetitive

Question 7

Fenfluramine is used in which of the following conditions?

Accepted Answer

Obesity

Answer

Malignancy

Answer

Hypertension

Answer

None of the above

Question 8

What is the significance of pKa in relation to a drug's ionization?

Accepted Answer

The pH at which 50% of the drug is ionized and 50% is non-ionized.

Answer

The pH at which 50% of the drug is in its active form.

Answer

The pH at which all of the drug is in its non-ionized form.

Answer

The pH at which all of the drug is in its ionized form.

Question 9

What is the mechanism of action of sildenafil?

Accepted Answer

Inhibition of phosphodiesterase-5

Answer

Inhibition of adenosine deaminase

Answer

Inhibition of Aminopeptidase

Answer

Inhibition of Guanylyl cyclase

Question 10

Sildenafil acts by which mechanism?

Accepted Answer

Increasing cGMP

Answer

Decreasing cGMP

Answer

Increasing cAMP

Answer

Decreasing cAMP

General Pharmacology — MCQs

General Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?